166 related articles for article (PubMed ID: 9552447)
1. Formulation development of sustained-release hydrophilic matrix tablets of zileuton.
Qiu Y; Hui HW; Cheskin H
Pharm Dev Technol; 1997 Aug; 2(3):197-204. PubMed ID: 9552447
[TBL] [Abstract][Full Text] [Related]
2. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
[TBL] [Abstract][Full Text] [Related]
3. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
[TBL] [Abstract][Full Text] [Related]
4. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
Franek F; Holm P; Larsen F; Steffansen B
Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
[TBL] [Abstract][Full Text] [Related]
5. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system.
Tiwari SB; Murthy TK; Pai MR; Mehta PR; Chowdary PB
AAPS PharmSciTech; 2003; 4(3):E31. PubMed ID: 14621963
[TBL] [Abstract][Full Text] [Related]
6. Study the effect of formulation variables on drug release from hydrophilic matrix tablets of milnacipran and prediction of in-vivo plasma profile.
Singhvi G; Shah A; Yadav N; Saha RN
Pharm Dev Technol; 2014 Sep; 19(6):708-16. PubMed ID: 23931031
[TBL] [Abstract][Full Text] [Related]
7. The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends.
Hamed R; AlJanabi R; Sunoqrot S; Abbas A
Drug Dev Ind Pharm; 2017 Aug; 43(8):1330-1342. PubMed ID: 28402145
[TBL] [Abstract][Full Text] [Related]
8. The effect of processing variables on the mechanical and release properties of tramadol matrix tablets incorporating Cissus populnea gum as controlled release excipient.
Adeleye OA; Femi-Oyewo MN; Odeniyi MA
Polim Med; 2014; 44(4):209-20. PubMed ID: 25932902
[TBL] [Abstract][Full Text] [Related]
9. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
10. Formulation of a poorly water-soluble drug in sustained-release hollow granules with a high viscosity water-soluble polymer using a fluidized bed rotor granulator.
Asada T; Yoshihara N; Ochiai Y; Kimura SI; Iwao Y; Itai S
Int J Pharm; 2018 Apr; 541(1-2):246-252. PubMed ID: 29496456
[TBL] [Abstract][Full Text] [Related]
11. Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method.
Qiu Y; Garren J; Samara E; Cao G; Abraham C; Cheskin HS; Engh KR
J Pharm Sci; 2003 Nov; 92(11):2317-25. PubMed ID: 14603516
[TBL] [Abstract][Full Text] [Related]
12. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
Baviskar D; Sharma R; Jain D
Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
[TBL] [Abstract][Full Text] [Related]
13. Formulation Development and Optimization of Matrix Tablet of Tramadol Hydrochloride.
Deb P; Singha J; Chanda I; Chakraborty P
Recent Pat Drug Deliv Formul; 2017; 11(1):19-27. PubMed ID: 27712568
[TBL] [Abstract][Full Text] [Related]
14. Release of pentoxifylline from xanthan gum matrix tablets.
El-Gazayerly ON
Drug Dev Ind Pharm; 2003 Feb; 29(2):241-6. PubMed ID: 12648021
[TBL] [Abstract][Full Text] [Related]
15. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
Park JS; Shim JY; Park JS; Choi YW; Jeong SH
Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708
[TBL] [Abstract][Full Text] [Related]
16. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
[TBL] [Abstract][Full Text] [Related]
17. [Studies on drug release from aminophylline konjac glucomannan matrix tablet].
Zhu GQ; Zhang Y; Liu JH
Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(21):2236-9. PubMed ID: 18309662
[TBL] [Abstract][Full Text] [Related]
18. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.
Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588
[TBL] [Abstract][Full Text] [Related]
19. Critical factors in the release of drugs from sustained release hydrophilic matrices.
Maderuelo C; Zarzuelo A; Lanao JM
J Control Release; 2011 Aug; 154(1):2-19. PubMed ID: 21497624
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
Avachat A; Kotwal V
AAPS PharmSciTech; 2007 Oct; 8(4):E88. PubMed ID: 18181548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
